Celia Egan
Internal Medicine · Grand Rapids, MINPI 1831488774
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $33,938 of the $53,927 with a category attached, or 62.9%. Novo Nordisk accounts for 63.9% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $31,477, more than ten times the $125 reported in 2019. Among internal medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $377.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$34K
- Novo Nordisk AS$18K
- Echosens North America, Inc.$185
- Astellas Pharma US Inc$170
- Pfizer$136
- Lilly USA, LLC$123
- plus $586 from 17 others
What the payments were for
- Consulting fees$33,93863%
- Travel & lodging$15,98530%
- Food & beverage$3,8347%
- Education$1710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 86 | $34,470 |
| Novo Nordisk AS | 6 | $18,258 |
| Echosens North America, Inc. | 1 | $185 |
| Astellas Pharma US Inc | 5 | $170 |
| Pfizer | 6 | $136 |
| Lilly USA, LLC | 5 | $123 |
| Mayne Pharma Commercial LLC | 8 | $110 |
| Amgen | 5 | $86 |
| Dexcom, Inc. | 2 | $51 |
| Bayer | 3 | $48 |
| Cashflow Solutions, LLC | 2 | $33 |
| Therapeuticsmd, Inc. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| AbbVie | 1 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Abbott | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Exact Sciences | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $18 |
| Vivus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$53,927 in reported general payments places this provider in the 95th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 24 | $24,547 |
| Metformin Hcl ErMetformin Hcl | 29 | $441 |
| Topiramate | 14 | $183 |
| Lisinopril | 14 | $103 |
| Lorazepam | 15 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $123 | $24,54724 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Grand Rapids
- Robert SelfeGrand Rapids$238K
- Jeremy GentileGrand Rapids$44K
- Terry SmithAnn Arbor$2.3M
- Michael ValituttoKalamazoo$1.8M
- Ulka VaishampayanAnn Arbor$996K
- Tina AbrahamPontiac$834K
- Steven KatzmanLivonia$715K
- Adam FormanSouthfield$453K
- Saroj NeupaneDetroit$373K
- James BazziDearborn Heights$368K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.